A Singapore biotech company announced Thursday that it has produced and stored four new clinically compliant human embryonic stem cell lines, and that another four lines should be stored within the next four to five weeks. ES Cell International believes it is the first in the world to create these cell lines under the strict cGMP, or current Good Manufacturing Practice, standards, but that claim has yet to be verified. All of the lines will be made available to academic researchers through A*STAR Singapore Stem Cell Consortium, according to the company.
Loading ...
Singapore Company Reports Stem Cell Progress
Posted by: Alexandra DeFelice July 28, 2006 05:27 PMA Singapore biotech company announced Thursday that it has produced and stored four new clinically compliant human embryonic stem cell lines, and that another four lines should be stored within the next four to five weeks. ES Cell International believes it is the first in the world to create these cell lines under the strict cGMP, or current Good Manufacturing Practice, standards, but that claim has yet to be verified. All of the lines will be made available to academic researchers through A*STAR Singapore Stem Cell Consortium, according to the company.